Cargando…
Silver Nanoforms as a Therapeutic Agent for Killing Escherichia coli and Certain ESKAPE Pathogens
The scope of this study included the preparation of silver nanoforms with high antimicrobial efficacy, low cost, and ease of application. The term ‘silver nanoforms’ refers to silver located on the amorphous or crystalline titanium dioxide (TiO(2)). Silver nanoforms may be used as an alternative to...
Autores principales: | Kedziora, A., Korzekwa, K., Strek, W., Pawlak, A., Doroszkiewicz, W., Bugla-Ploskonska, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899487/ https://www.ncbi.nlm.nih.gov/pubmed/27086305 http://dx.doi.org/10.1007/s00284-016-1034-8 |
Ejemplares similares
-
Similarities and Differences between Silver Ions and Silver in Nanoforms as Antibacterial Agents
por: Kędziora, Anna, et al.
Publicado: (2018) -
Benefits of Usage of Immobilized Silver Nanoparticles as Pseudomonas aeruginosa Antibiofilm Factors
por: Korzekwa, Kamila, et al.
Publicado: (2021) -
Consequences Of Long-Term Bacteria’s Exposure To Silver Nanoformulations With Different PhysicoChemical Properties
por: Kędziora, Anna, et al.
Publicado: (2020) -
Analysis of the SDS-PAGE patterns of outer membrane proteins from Escherichia coli strains that have lost the ability to form K1 antigen and varied in the susceptibility to normal human serum
por: Cisowska, Agnieszka, et al.
Publicado: (2013) -
The Phylogenetic Structure of Reptile, Avian and Uropathogenic Escherichia coli with Particular Reference to Extraintestinal Pathotypes
por: Książczyk, Marta, et al.
Publicado: (2021)